Position in AXGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,378,999
+$679,593 QoQ
Shares Held
71,808
+38.3% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026SEI INVESTMENTS CO holds $872,986,178 across 71 Medical Devices names. AXGN ranks #36 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
1,244,868 | $107,867,811 | |
| 2 | EW |
Edwards Lifesciences Corp
|
1,239,001 | $99,219,199 | |
| 3 | BIO |
Bio-Rad Laboratories, Inc.
|
287,912 | $80,255,469 | |
| 4 | SYK |
Stryker Corp
|
229,287 | $75,341,413 | |
| 5 | BSX |
Boston Scientific Corp
|
1,021,347 | $64,089,523 | |
| 6 | ABT |
Abbott Laboratories
|
529,317 | $54,344,976 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
411,962 | $37,249,603 | |
| 8 | CNMD |
CONMED Corp
|
1,004,715 | $35,526,722 |
All Filings in AXGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,378,999 | 71,808 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,699,406 | 51,922 | Shares | Defined | 2026-02-13 | |
| 2025-03-31 | $605,338 | 32,721 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $187,608 | 11,384 | Shares | Sole | 2025-02-11 | |
| 2020-03-31 | $317,938 | 30,571 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||